FDA Drug recall D-1180-2022
Enalapril Maleate Tablets, USP
- FDA Drug
- Class II
- ongoing
- Published 2022-07-13
On 2022-07-13 the FDA classified a Class II recall of Enalapril Maleate Tablets, USP by Golden State Medical Supply, citing CGMP Deviations.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1180-2022 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2022-03-16 |
| Published | 2022-07-13 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Golden State Medical Supply |
| Distribution | US |
Product
Enalapril Maleate Tablets, USP; 20 mg; 90 tablets, NDC 60429-186-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.
Reason
CGMP Deviations
Identifiers
| ndc | 60429-183-30 |
|---|---|
| ndc | 60429-183-10 |
| ndc | 60429-183-90 |
| ndc | 60429-184-30 |
| ndc | 60429-184-10 |
| ndc | 60429-184-90 |
| ndc | 60429-185-30 |
| ndc | 60429-185-10 |
| ndc | 60429-185-90 |
| ndc | 60429-186-30 |
| ndc | 60429-186-10 |
| ndc | 60429-186-90 |
| code_info | Lots: GS035031, GS035199, 20 mg; 90 tablets, Exp.: 03/2022; Lots: GS036495, GS036904, Exp.: 05/2022; Lots: GS037401, E…Lots: GS035031, GS035199, 20 mg; 90 tablets, Exp.: 03/2022; Lots: GS036495, GS036904, Exp.: 05/2022; Lots: GS037401, Exp.: 09/2022; Lots: GS037986, GS038359, GS039560, Exp.: 11/2022; Lot: GS041110, Exp.: 12/2022. (NDC: 60429-186-90). |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1180-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.